Skip to main content
. 2018 Mar 22;9:182. doi: 10.3389/fneur.2018.00182

Table 2.

Sample description for cytokine production analysis.

Characteristic CP cases Control


Total (%) M/F (n) Total (%) M/F (n)
Type of CP
CP with spastic tetraplegia 23 (24.2) 11/12
CP with spastic deplegia 35 (36.8) 21/14
CP with spastic hemiplegia 8 (8.4) 7/1
CP without spastic 29 (30.5) 17/12

Total 95 (100) 56/39 93 (100) 78/15

Birth asphyxia
No asphyxia 58 (61.1) 31/27 91 (97.8) 77/14
Asphyxia 37 (38.9) 25/12 2 (2.2) 1/1

Total 95 (100) 56/39 93 (100) 78/15

Complication
With PVL 23 (24.2) 14/9
Without PVL 72 (75.8) 42/30
With MR 75 (78.9) 40/35
Without MR 20 (21.1) 16/4
With HIE 7 (7.4) 5/2
Without HIE 88 (92.6) 51/37
Maternal factors
PROM 20 (21.1) 11/9 7 (7.5) 6/1
No PROM 75 (78.9) 47/28 86 (92.5) 72/14
TPL 23 (24.2) 16/7 17 (18.3) 13/4
No TPL 72 (75.8) 40/32 76 (81.7) 65/11
PIH 9 (9.5) 5/4 6 (6.5) 5/1
No PIH 86 (90.5) 51/35 87 (93.5) 73/14

CP, cerebral palsy; M, male; F, female; HIE, hypoxia ischemia encephalopathy; PVL, periventricular leukomalacia; MR, mental retardation; PROM, premature rupture of membrane; TPL, threatened premature labor; PIH, pregnancy-induced hypertension.